These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25149833)

  • 1. Subacute sclerosing panencephalitis: clinical and demographic characteristics.
    Rafique A; Amjad N; Chand P; Zaidi SS; Rana MS; Ahmed K; Ibrahim S
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):557-60. PubMed ID: 25149833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile of subacute sclerosing panencephalitis.
    Akram M; Naz F; Malik A; Hamid H
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):485-8. PubMed ID: 18798579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
    Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
    J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological study of subacute sclerosing panencephalitis in Japan, 1976.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Sato T; Isomura S; Ueda S; Kitamura I; Kaji M
    Biken J; 1978 Mar; 21(A):9-14. PubMed ID: 666722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
    Ibrahim SH; Amjad N; Saleem AF; Chand P; Rafique A; Humayun KN
    J Trop Pediatr; 2014 Dec; 60(6):449-53. PubMed ID: 25232151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and epidemiological characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978-2002).
    Bojinova VS; Dimova PS; Belopitova LD; Mihailov AS; Gatcheva NL; Mihneva ZG; Hristova MT
    Eur J Paediatr Neurol; 2004; 8(2):89-94. PubMed ID: 15253056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated ratio of late measles among subacute sclerosing panencephalitis patients in Karachi, Pakistan.
    Takasu T; Kondo K; Ahmed A; Yoshikawa Y; Yamanouchi K; Tsuchiya M; Murakami N; Ueda S
    Neuroepidemiology; 1992; 11(4-6):282-7. PubMed ID: 1291892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing epidemiological features of subacute sclerosing panencephalitis.
    Anlar B; Köse G; Gürer Y; Altunbaşak S; Haspolat S; Okan M
    Infection; 2001 Aug; 29(4):192-5. PubMed ID: 11545478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subacute sclerosing panencephalitis (SSPE) in Poland 1984-1986. Stage III of epidemiologic studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1988; 42(3):205-10. PubMed ID: 3254552
    [No Abstract]   [Full Text] [Related]  

  • 18. [Subacute sclerosing panencephalitis cases diagnosed by increased CSF/serum measles antibody indices].
    Samlıoğlu P; Unalp A; Gökçay A; Altuğlu I; Oztürk A; Zeytinoğlu A
    Mikrobiyol Bul; 2012 Oct; 46(4):716-8. PubMed ID: 23188587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiological aspects of SSPE].
    Nihei K
    Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies].
    Naruszewicz-Lesiuk D; Iwińska-Buksowicz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Neurol Neurochir Pol; 2000; 34(5):877-85. PubMed ID: 11253477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.